Global Oxytocin Market Insights, Forecast to 2028

Oxytocin (Oxt) is a peptide hormone and neuropeptide. Oxytocin is normally produced in the hypothalamus and released by the posterior pituitary. It plays an important role in the female reproductive system, particularly with childbirth and breast-feeding.
Market Analysis and Insights: Global Oxytocin Market
Due to the COVID-19 pandemic, the global Oxytocin market size is estimated to be worth US$ 30 million in 2022 and is forecast to a readjusted size of US$ 39 million by 2028 with a CAGR of 4.8% during the review period. Fully considering the economic change by this health crisis, Injection accounting for % of the Oxytocin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While For Baby Born segment is altered to an % CAGR throughout this forecast period.
China Oxytocin market size is valued at US$ million in 2021, while the US and Europe Oxytocin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oxytocin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Oxytocin include Hybio Pharmaceutical, Pfizer, Mylan, GSK, Novartis, Grindeks, Ningbo Renjian Pharmaceutical Group, Nanjing Xinbai Pharmaceutical and Shanghai Harvest Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oxytocin Scope and Segment
Oxytocin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oxytocin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Injection
Nasal Spray

Segment by Application
For Baby Born
For Comestic
Others

By Company
Hybio Pharmaceutical
Pfizer
Mylan
GSK
Novartis
Grindeks
Ningbo Renjian Pharmaceutical Group
Nanjing Xinbai Pharmaceutical
Shanghai Harvest Pharmaceutical
Suzhou Tianji Bio-Pharmaceutical
Chengdu Hepatunn
SPH NO.1 Biochemical & Pharmaceutical
Shanghai Ceneral Pharmaceutical
Anhui Hongye Pharmaceutical
Tianjin Biochem Pharmaceutical

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E